Erythropoietin Stimulating Agents Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysi
Erythropoietin Stimulating Agents Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Global Erythropoietin Stimulating Agents Market: By Product Type (Epoetin-Alfa, Epoetin-Beta, Epoetin-Delta, Epoetin-Omega, Darbepoetin-Alfa, Others), By Application (Oncology, Renal Disorders, Anemia, Surgeries, Others), By Distribution Channel (Hospital Pharmacies, retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Global erythropoietin stimulating agents market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.
Market Outline: Global Erythropoietin Stimulating Agents Market
Erythropoietin is a hormone produced by kidney that enables stimulate production of RBC. Erythropoietin stimulating agents are the drugs used to stimulate the bone marrow to enhance the production of red blood cells. The drugs are commonly used in the treatment of anemia due to end stage renal disease (ESRD), major surgeries, chemotherapy, and HIV/AIDS leads to decrease the need of blood transfusion.
Market Dynamics: Global Erythropoietin Stimulating Agents Market
Rise in prevalence of anemia, ESRD, HIV, and cancer around the globe is witnessed to increased demand for global erythropoietin stimulating agents market. Moreover, rise in R&D for innovation of newer drugs, entry of bio-similar and generics into market due to expiration of patents are expected to increase in the adoption of low-cost drugs in developing countries, and rise in awareness about the benefits erythropoietin drugs are anticipated to propel the erythropoietin stimulating agents market over the forecast period. However, stringent regulations for the product approval, adverse effects associated with drugs, and high cost of patented drugs are impede the growth of erythropoietin stimulating agents market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Global Erythropoietin Stimulating Agents Market
Erythropoietin stimulating agents market is segmented on the basis of product type, application and distribution channel
Based on the product type, the market is segmented into the following:
• Epoetin-Alfa
• Epoetin-Beta
• Epoetin-Delta
• Epoetin-Omega
• Darbepoetin-Alfa
• Others
Based on the route of application, the market is segmented into the following:
• Oncology
• Renal Disorders
• Anemia
• Surgeries
• Others
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Global Erythropoietin Stimulating Agents Market
Geographically, global erythropoietin stimulating agents market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America erythropoietin stimulating agents market is expected to dominate the revenue share due to increase in the prevalence of anemia, rise in number of major surgical procedures, and development of biosimilar by market players are expected to fuel the market. Europe erythropoietin stimulating agents market is driven by increase in the incidence of cancers in UK, Germany, and France, rise in awareness about the erythropoietin drugs, increase in the R&D investment for the development of newer drugs are expected to surge the market. However, Asia Pacific erythropoietin stimulating agents market is witnessed enormous growth opportunities due to increase in the medical tourism in Asia Pacific countries, adoption of newer drugs, and launch of generic drugs into Asia Pacific market are expected to drive the market.
Competition Assessment: Global Erythropoietin Stimulating Agents Market
Some of the players in the global erythropoietin stimulating agents market include:
• Teva Pharmaceutical Industries Ltd. (Israel)
• Biocon Limited (India)
• Celltrion, Inc. (South Korea)
• Hoffmann La Roche, Ltd. (Switzerland)
• Hospira, Inc. (Pfizer, Inc.) (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Amgen, Inc. (U.S.)
• Dr. Reddy’s Laboratories Ltd (India)
• Intas Pharmaceuticals (India)
• 3SBio, Inc. (China)
• Kissei Pharmaceuticals Ltd (Japan)
Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-14mlyhjMGhVjZqa3
Notable Market Developments: Erythropoietin Stimulating Agents Market
• In January 2018, Kissei Pharmaceutical Company and JCR Pharmaceuticals announced positive results of Phase 3 study for JR-131, a biosimilar for darbopoetin alfs.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com